SCHEMBL13153140

SCHEMBL13153140

CN[C@H]1CCN(c2cc(N)n3ncc(Cl)c3n2)C1

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 20/20 0.53
▸ HRH3 Q9Y5N1 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14543100 0.86 HRH4 (0.53) HRH4HRH3
SCHEMBL15146127 0.86 HRH4 (0.53) HRH4HRH3
SCHEMBL11930837 0.83 HRH4 (0.49) HRH4HRH3
SCHEMBL13153479 0.77 HRH4 (0.45) HRH4HRH3
SCHEMBL14545856 0.71 CHEK1 (0.40) HRH4HRH3
SCHEMBL15393808 0.71 HRH4 (0.51) HRH4HRH3
SCHEMBL15393799 0.71 HRH4 (0.51) HRH4HRH3
SCHEMBL28173499 0.71 HRH4 (0.77) HRH4HRH3
SCHEMBL14516590 0.70 HRH4 (0.51) HRH4HRH3
SCHEMBL606210 0.70 HRH4 (1.00) HRH4HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010124009-A2 FULLY HUMAN ANTI-VEGF ANTIBODIES AND METHODS OF USING SCHERING CORPORATION (US) 2010-10-28 — — WO disclosed
WO-2008130569-A1 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2008-10-30 — — WO disclosed
Send feedback